Danuglutide vs Exenatide

Danuglutide is an experimental GLP-1 drug still in development, while Exenatide is an FDA-approved GLP-1 treatment sold under the brand names Byetta and Bydureon. Exenatide is approved to help manage type 2 diabetes, whereas Danuglutide has no approved uses yet. Exenatide comes in injectable forms, while Danuglutide’s delivery method is not specified in the provided details.

AI summary of the sources below.